f.villalobos

TL2 Moderator · Bursa

Contributes reviews on supplier material. Based in Bursa.

Joined 12 May 2025 · last posted 3d · groups: regional-apac

79Posts here

2Topics

1Solutions

197Likes received

161Likes given

23Badges

95Days visited

543Posts read

Recent activity

Full stream

[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #87 · Practice › Interactions · 25 Jul 2026 · 30 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #112 · Evidence › Journal club · 24 Jul 2026 · 20 likes On post #108 — agreed on the reasoning, with one qualification. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
Ultrasound and skinfolds: operator dependence in practice Replied, post #72 · Outcomes › Body composition · 23 Jul 2026 · 14 likes On post #68 — agreed on the reasoning, with one qualification. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary…
Talking to a therapist about this specifically Replied, post #23 · Wellbeing › Mental health · 21 Jul 2026 · 20 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
Type 1 diabetes: off-label use and the evidence gap Replied, post #2 · marked as the solution · Clinical › Special populations · 17 Jul 2026 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #58 · Evidence › Journal club · 13 Jul 2026 · 8 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
What to bring: records that a clinician can actually use — a second dataset Replied, post #11 · Clinical › Prescriber conversations · 6 Jul 2026 · 13 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
Search filters: what is missing Replied, post #77 · Meta › Site feedback · 5 Jul 2026 · 0 likes This follows post #74 rather than contradicting it. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #66 · Sourcing › Independent verification · 5 Jul 2026 · 22 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
What to include when your question involves a chromatogram — one year on Replied, post #49 · Start Here › How to Ask · 24 Jun 2026 · 24 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #67 · Safety › Contraindications · 9 Jun 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #25 · Compounds › Semaglutide · 7 Jun 2026 · 9 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…